Dichotomous effect of methylphenidate on microglia and astrocytes: Insights from in vitro and animal studies

Evidence-based pharmacological treatment options for ADHD in children and adolescents

(2021) Konstantin Mechler et al.   PHARMACOLOGY & THERAPEUTICS

The effect of parthenolide on methamphetamine‐induced blood‐brain barrier and astrocyte alterations

(2021) Ricardo A. Leitão et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Psychiatric Comorbidity and Stress in Medical Students Using Neuroenhancers

(2021) Tarek Jebrini et al.   Frontiers in Psychiatry

Astrocytes and Microglia: In Sickness and in Health

(2020) Ilia D. Vainchtein et al.   TRENDS IN NEUROSCIENCES

Chronic administration of methylphenidate did not affect memory and GDNF levels but increase astrogliosis in adult male rat’s hippocampus

(2020) Gholam Hossein Meftahi et al.   JOURNAL OF CHEMICAL NEUROANATOMY

TNF-alpha-induced microglia activation requires miR-342: impact on NF-kB signaling and neurotoxicity

(2020) João Paulo Brás et al.   Cell Death & Disease

Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder

(2020) Samuele Cortese   NEW ENGLAND JOURNAL OF MEDICINE

Students’ stimulant use for cognitive enhancement: A deliberate choice rather than an emotional response to a given situation

(2020) Koen Ponnet et al.   DRUG AND ALCOHOL DEPENDENCE

Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence

(2019) Helga Krinzinger et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Astrocytic Oxidative/Nitrosative Stress Contributes to Parkinson’s Disease Pathogenesis: The Dual Role of Reactive Astrocytes

(2019) Asha Rizor et al.   Antioxidants

Impact of developmental exposure to methylphenidate on rat brain’s immune privilege and behavior: Control versus ADHD model

(2018) Vanessa Coelho-Santos et al.   BRAIN BEHAVIOR AND IMMUNITY

The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities

(2018) Stephen V. Faraone   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Chronic oral methylphenidate treatment increases microglial activation in rats

(2018) Emily Carias et al.   JOURNAL OF NEURAL TRANSMISSION

Effect of chronic methylphenidate treatment on hippocampal neurovascular unit and memory performance in late adolescent rats

(2018) Vanessa Coelho-Santos et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Overuse of methylphenidate: an analysis of Swedish pharmacy dispensing data

(2018) Pernilla J Bjerkeli et al.   Clinical Epidemiology

Aquaporin-4 as a New Target against Methamphetamine-Induced Brain Alterations: Focus on the Neurogliovascular Unit and Motivational Behavior

(2017) Ricardo Alexandre Leitão et al.   MOLECULAR NEUROBIOLOGY

First evidence that waterborne methylphenidate alters endocrine and behavioral stress responses in zebrafish

(2017) Helena Cristina Endres et al.   NEUROSCIENCE LETTERS

Neurocognitive enhancement or impairment? A systematic meta-analysis of prescription stimulant effects on processing speed, decision-making, planning, and cognitive perseveration.

(2016) Marisa E. Marraccini et al.   EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY

Pharmacological and Nonpharmacological Treatment for Apathy in Alzheimer Disease

(2016) Christos Theleritis et al.   JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Effects of acute doses of methylphenidate on inflammation and oxidative stress in isolated hippocampus and cerebral cortex of adult rats

(2016) Majid Motaghinejad et al.   JOURNAL OF NEURAL TRANSMISSION

Methylphenidate Causes Behavioral Impairments and Neuron and Astrocyte Loss in the Hippocampus of Juvenile Rats

(2016) Felipe Schmitz et al.   MOLECULAR NEUROBIOLOGY

Effects of chronic treatment with methylphenidate on oxidative stress and inflammation in hippocampus of adult rats

(2016) Majid Motaghinejad et al.   NEUROSCIENCE LETTERS

Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure–induced transient ischemic injury

(2016) Maria H. Madeira et al.   Translational Research

Citalopram, Methylphenidate, or Their Combination in Geriatric Depression: A Randomized, Double-Blind, Placebo-Controlled Trial

(2015) Helen Lavretsky et al.   AMERICAN JOURNAL OF PSYCHIATRY

Effect of Methylphenidate in Patients with Cancer-Related Fatigue: A Systematic Review and Meta-Analysis

(2014) Shun Gong et al.   PLoS One

Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway

(2012) Vanessa Coelho-Santos et al.   Journal of Neuroinflammation

Methylphenidate Exposure Induces Dopamine Neuron Loss and Activation of Microglia in the Basal Ganglia of Mice

(2012) Shankar Sadasivan et al.   PLoS One

The Roles of Dopamine and Noradrenaline in the Pathophysiology and Treatment of Attention-Deficit/Hyperactivity Disorder

(2011) Natalia del Campo et al.   BIOLOGICAL PSYCHIATRY

Neuropeptide Y inhibits interleukin-1 beta-induced microglia motility

(2011) Raquel Ferreira et al.   JOURNAL OF NEUROCHEMISTRY

Methylphenidate and μ opioid receptor interactions: A pharmacological target for prevention of stimulant abuse

(2011) Jinmin Zhu et al.   NEUROPHARMACOLOGY

Neurobiology of ADHD

(2009) Gail Tripp et al.   NEUROPHARMACOLOGY